EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance

Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Stefan Kim, Mayur Sharma, Johnny Akers, Thien Nguyen, Eric Wong, Margot Martinez Moreno, Efrosini Kokkoli, Shobha Vasudevan, Sean E Lawler und 3 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Gatikrushna Singh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: gsingh@umn.edu. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIH NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intratumoral heterogeneity plays a pivotal role in cancer evolution, providing the substrate for adaptation to selective pressures, including chemotherapy treatment. Here, we demonstrate that miR-181d modulates variability in methyl-guanine methyl transferase (MGMT) expression, contributing to this heterogeneity in glioblastoma, the most common form of adult primary brain tumor. Treatment with standard-of-care temozolomide (TMZ) chemotherapy triggers a feedforward loop that accelerates polyribonucleotide nucleotidyltransferase 1 (PNPT1)-dependent miR-181d degradation. This degradation requires the activation of ataxia-telangiectasia and Rad3-related (ATR) kinase. The degradation of miR-181d in glioblastoma cells increases the variance of MGMT expression in the cell population, contributing to acquired TMZ resistance. This resistance is suppressed by exogenously transfected miR-181d. These findings suggest that microRNA regulates intratumoral heterogeneity by modulating the transcriptional variability of key DNA repair enzymes, providing a compelling rationale for miRNA delivery as a platform for glioblastoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrug Resistance, NeoplasmGlioblastomaBrain NeoplasmsDNA Repair EnzymesTumor Suppressor ProteinsDacarbazineDNA Modification MethylasesTemozolomideHumansCell Line, TumorAtaxia Telangiectasia Mutated ProteinsAntineoplastic Agents, AlkylatingGene Expression Regulation, NeoplasticExoribonucleases

Stichwörter der Autor:innen

ATRCP: cancerMGMTPNPT1glioblastomamicroRNAtemozolomide

Substanzen

MicroRNAsTemozolomideMIrn181 microRNA, humanAtaxia Telangiectasia Mutated ProteinsDNA Repair EnzymesMGMT protein, humanTumor Suppressor ProteinsDacarbazineDNA Modification MethylasesAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: gsingh@umn.edu.
  • Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Veterinary Biomedical Sciences, St. Paul, MN 55108, USA.
  • VisiCELL Medical Inc., San Diego, CA 92121, USA.
  • Department of Pediatrics, Stanford University, Stanford, CA 94304, USA.
  • Department of Neurology, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI 02903, USA.

Förderung

  • NINDS NIH HHS
  • NIH NCI

Zitieren

APA

Singh, G., Singh, S., Mohapatra, I., Kim, S., Sharma, M., Akers, J., Nguyen, T., Wong, E., Moreno, M. M., Kokkoli, E., Vasudevan, S., Lawler, S. E., El-Deiry, W. S., Gokaslan, Z., & Chen, C. C. (2025). Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116516

Vancouver

Singh G, Singh S, Mohapatra I, Kim S, Sharma M, Akers J, et al. Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116516

BibTeX
@article{Singh2025,
  author = {Singh, Gatikrushna and Singh, Shilpi and Mohapatra, Iteeshree and Kim, Stefan and Sharma, Mayur and Akers, Johnny and Nguyen, Thien and Wong, Eric and Moreno, Margot Martinez and Kokkoli, Efrosini and Vasudevan, Shobha and Lawler, Sean E and El-Deiry, Wafik S and Gokaslan, Ziya and Chen, Clark C},
  title = {Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116516}
}
Kostenlos starten →